Test Code ESTF Estrogens, Estrone (E1) and Estradiol (E2), Fractionated, Serum
Additional Codes
Outreach (Atlas) Order Code
ESTF
Hospital (Cerner) Order Code
ESTF
Reporting Name
Estrogens, E1+E2, fractionated, SUseful For
Simultaneous high-sensitivity determination of serum estrone and estradiol levels
Situations requiring either higher sensitivity estradiol measurement, estrone measurement, or both, including
-As part of the diagnosis and workup of precocious and delayed puberty in females and, to a lesser degree, males
-As part of the diagnosis and workup of suspected disorders of sex steroid metabolism, (eg, aromatase deficiency and 17 alpha-hydroxylase deficiency)
-As an adjunct to clinical assessment, imaging studies, and bone mineral density measurement in the fracture risk assessment of postmenopausal women and, to a lesser degree, older men
-Monitoring low-dose female hormone replacement therapy in postmenopausal women
-Monitoring antiestrogen therapy (eg, aromatase inhibitor therapy)
Applications that require moderately sensitive measurement of estradiol including:
-Evaluation of hypogonadism and oligo-amenorrhea in females
-Assessing ovarian status, including follicle development, for assisted reproduction protocols (eg, in vitro fertilization)
In conjunction with luteinizing hormone measurements, monitoring of estrogen replacement therapy in hypogonadal premenopausal women
Evaluation of feminization, including gynecomastia, in males
Diagnosis of estrogen-producing neoplasms in males, and, to a lesser degree, females
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
E1 | Estrone, S | Yes | Yes |
EEST | Estradiol, Mass Spectrometry, S | Yes | Yes |
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
Serum RedSpecimen Required
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Collection Container/Tube: Red top (Serum gel/SST is not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume:1.2 mL
Collection Instructions: Within 2 hours of collection centrifuge and aliquot serum in plastic vial within 2 hours of collection.
Additional Information: For more information see Steroid Pathways.
Specimen Minimum Volume
0.7mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 28 days | |
Ambient | 28 days | ||
Frozen | 28 days |
Reference Values
ESTRONE (E1)
CHILDREN*
1 to14 days: Estrone levels in newborns are very elevated at birth but will fall to prepubertal levels within a few days.
Males
Tanner stages# |
Mean age |
Reference range |
Stage I (>14 days and prepubertal) |
7.1 years |
Undetectable-16 pg/mL |
Stage II |
11.5 years |
Undetectable-22 pg/mL |
Stage III |
13.6 years |
10-25 pg/mL |
Stage IV |
15.1 years |
10-46 pg/mL |
Stage V |
18 years |
10-60 pg/mL |
#Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for boys at a median age of 11.5 (± 2) years. For boys there is no proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
Females
Tanner stages# |
Mean age |
Reference range |
Stage I (>14 days and prepubertal) |
7.1 years |
Undetectable-29 pg/mL |
Stage II |
10.5 years |
10-33 pg/mL |
Stage III |
11.6 years |
15-43 pg/mL |
Stage IV |
12.3 years |
16-77 pg/mL |
Stage V |
14.5 years |
17-200 pg/mL |
#Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for girls at a median age of 10.5 (± 2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African American girls. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
*The reference ranges for children are based on the published literature,(1,2) cross-correlation of our assay with assays used to generate the literature data and on our data for young adults.
ADULTS
Males: 10-60 pg/mL
Females
Premenopausal: 17-200 pg/mL
Postmenopausal: 7-40 pg/mL
Conversion factor
E1: pg/mL x 3.704=pmol/L (molecular weight=270)
ESTRADIOL (E2)
CHILDREN*
1 to14 days: Estradiol levels in newborns are very elevated at birth but will fall to prepubertal levels within a few days.
Males
Tanner stages# |
Mean age |
Reference range |
Stage I (>14 days and prepubertal) |
7.1 years |
Undetectable-13 pg/mL |
Stage II |
12.1 years |
Undetectable-16 pg/mL |
Stage III |
13.6 years |
Undetectable-26 pg/mL |
Stage IV |
15.1 years |
Undetectable-38 pg/mL |
Stage V |
18 years |
10-40 pg/mL |
#Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for boys at a median age of 11.5 (± 2) years. For boys there is no proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
Females
Tanner stages# |
Mean age |
Reference range |
Stage I (>14 days and prepubertal) |
7.1 years |
Undetectable-20 pg/mL |
Stage II |
10.5 years |
Undetectable-24 pg/mL |
Stage III |
11.6 years |
Undetectable-60 pg/mL |
Stage IV |
12.3 years |
15-85 pg/mL |
Stage V |
14.5 years |
15-350 pg/mL** |
#Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for girls at a median age of 10.5 (± 2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African American girls. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
*The reference ranges for children are based on the published literature,(1,2) cross-correlation of our assay with assays used to generate the literature data and on our data for young adults.
ADULTS
Males: 10-40 pg/mL
Females
Premenopausal: 15-350 pg/mL**
Postmenopausal: <10 pg/mL
**E2 levels vary widely through the menstrual cycle.
Conversion factor
E2: pg/mL x 3.676=pmol/L (molecular weight=272)
For International System of Units (SI) conversion for Reference Values, see https://www.mayocliniclabs.com/order-tests/si-unit-conversion.html
Day(s) Performed
Monday through Saturday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82671-Estrogens, fractionated
82670-Estradiol (If applicable)
82679-Estrone (If applicable)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ESTF | Estrogens, E1+E2, fractionated, S | 53766-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
81418 | Estrone, S | 2258-2 |
81816 | Estradiol, Mass Spectrometry, S | 2243-4 |
Report Available
2 to 6 daysReject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)